188686-10-4

Basic information

• Product Name: (S)-3-[3-Hydroxy-2-(2-methoxy-ethoxymethoxy)-3-(4-methoxy-phenyl)-propionyl]-4-isopropyl-oxazolidin-2-one
• Synonyms: (S)-3-[3-Hydroxy-2-(2-methoxy-ethoxymethoxy)-3-(4-methoxy-phenyl)-propionyl]-4-isopropyl-oxazolidin-2-one
• CAS NO: 188686-10-4
• Molecular Weight: 411.452
• Mol File: 188686-10-4.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: (S)-3-[3-Hydroxy-2-(2-methoxy-ethoxymethoxy)-3-(4-methoxy-phenyl)-propionyl]-4-isopropyl-oxazolidin-2-one(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-3-[3-Hydroxy-2-(2-methoxy-ethoxymethoxy)-3-(4-methoxy-phenyl)-propionyl]-4-isopropyl-oxazolidin-2-one(188686-10-4)
• EPA Substance Registry System: (S)-3-[3-Hydroxy-2-(2-methoxy-ethoxymethoxy)-3-(4-methoxy-phenyl)-propionyl]-4-isopropyl-oxazolidin-2-one(188686-10-4)

Safety Data

• Hazardous Substances Data: 188686-10-4(Hazardous Substances Data)

Upstream product

• 17016-83-0 (4S)-4-isopropyl-1,3-oxazolidin-2-one 
• 123-11-5 4-methoxy-benzaldehyde 
• 928007-17-4 (S)-3-(2-methoxyethoxy)methyloxyacetyl-4-(1-methylethyl)-2-oxazolidinone 

Downstream Products

• 142142-08-3 (2S,3S)-3-(2-Methoxy-ethoxymethoxy)-2-(4-methoxy-phenyl)-2,3-dihydro-5H-benzo[b][1,4]thiazepin-4-one 
• 42399-49-5 (2S,3S)-3-hydroxy-2-(4-methoxyphenyl)-2,3-dihydro-1,5-benzothiazepin-4(5H)-one 
• 136088-21-6 (S)-3-[(2S,3S)-3-(2-Amino-phenylsulfanyl)-2-(2-methoxy-ethoxymethoxy)-3-(4-methoxy-phenyl)-propionyl]-4-isopropyl-oxazolidin-2-one 
• 136057-77-7 (S)-4-Isopropyl-3-[(Z)-2-(2-methoxy-ethoxymethoxy)-3-(4-methoxy-phenyl)-acryloyl]-oxazolidin-2-one 
• 136057-78-8 (S)-4-Isopropyl-3-[(E)-2-(2-methoxy-ethoxymethoxy)-3-(4-methoxy-phenyl)-acryloyl]-oxazolidin-2-one 

Relevant articles and documents

Asymmetric induction at two contiguous stereogenic centers by diastereoface differentiating nucleophilic addition reaction

Distereoface differentiating nucleophilic of thiophenol to olefins delivers a new concomitant asymmetric construction of two contiguous stereogenic centers and has been successfully applied to the asymmetric synthesis of (+)-diltiazem.